4
BRIEF COMMUN ICATION Submucosal esophageal hematon1a fallowing sclerotherapy: A rare complication RAM SINGH. YK C HAWLA , UPJEET KA UR. NEELAM MALIK. JB DILAWARI ABSTRACT: A cirrhotic patient who developed an intramural hematoma of the esophagus as a complication of esophagea l va ri ceal sclerotherapy is reported. The hematoma resolved spontaneo usly within two wee ks without any residu al complications such as esophageal stricture. Can J Gastroenterol 1990;4( 1 )123·25 Key Words: Hematoma, Portal hypertension , Sclerotherapy Hematome oesophagien sous•muqueux consecutif a une sclero· therapie: Une complication rare RESUME: Un patient cirrh otique a developpe un he matome intramural de l'oesophage, comp lication d' une sclerotherapie administree clans le traitement des varices oesophagiennes. L'hematome s'est resolu spon taneme nt en l'espace de deux semaines sans aucune comp lication residue lle - ste nose esop hagienne, par exem pie. E NDOSCOPIC SCLEROTHERAl'Y IS NOW considered an important therapeutic mod ali ty in the management of va riceal hemorrhages. There is now enoug h data to show that e ndoscopic sclerot herapy significa ntly reduces rebleeding risk ( 1-3 ); howeve r, its effect on the surv iv al of pa- tients with cirrh osis is still controversial (2-4). Various comp lications of endo - scopic sclerotherapy have been described in the literature (5,6). This report deals with an extre mely unusual comp lication. D epartments of H e/>awlogy, Experimencal Medicine and Rad1odiagnosis , Pos rgraduate ln.mrute o{Medical Education and Research, Chandigarh- 16001 2, India Correspondence and reprint1. Dr JB Dilawari, Associate P rofessor and Head, Departmenr of Hepawlogy, Postgraduate lnsti rute of Medical Education and R esearch, Cha11d1garh- 16001 2. Ind ia Received/or publi ca rion]unc 7. 1989. Accepted September 9, !989 CAN J GASTROENTEROL VOL 4 No l JANUARY/FEBRUARY 1990 CASE PRESENTATION A 55-ycar-olJ female prese nt ed in September 1 986 wirh massive hemate- mesi~ and mclena, which were diagnosed to be variceal in o ri gin on endoscopy. She had normal liver function tests; how- ever, a biopsy of the liver showed ci r- rhosis. After initi al control of the bl eed usi ng a Sengstaken-Blakemore tube, the patient was started on endoscopic sclero- therapy (EST). EST was performed with I% so dium tetradecyl s ulphate at three- week intervals using an O lympus fibre- sco pe. The varices decreased in si ze from grade lll co g ra de II after six sessi ons . During the seventh session of sclero- thcrapy, one grade II va ri x was injected with I mLof the sclerosant. The patient did not complain of pa in du ring or imm- ed iately after the procedure . Over the next 12 h, however, she devel oped a pro· gressive dysphagia to both solids and liq- uids including saliva, al ong with severe retrosternal pain . On examination there was no hepato· splenomegaly and the lung s were clear. The patient had a no rmal coagulogra m which was done soon aft er the compli- ca ti on occurr ed . 23

Submucosal esophageal hematon1a fallowing sclerotherapy: A …downloads.hindawi.com/journals/cjgh/1990/715941.pdf · BRIEF COMMUNICATION Submucosal esophageal hematon1a fallowing

  • Upload
    others

  • View
    6

  • Download
    0

Embed Size (px)

Citation preview

Page 1: Submucosal esophageal hematon1a fallowing sclerotherapy: A …downloads.hindawi.com/journals/cjgh/1990/715941.pdf · BRIEF COMMUNICATION Submucosal esophageal hematon1a fallowing

BRIEF COMMUNICATION

Submucosal esophageal hematon1a fallowing sclerotherapy:

A rare complication

RAM SINGH. YK C HAWLA, UPJEET KAUR. NEELAM MALIK.JB DILAWARI

ABSTRACT: A cirrhotic patient who developed an intramural hematoma of the esophagus as a complication of esophageal variceal sclerotherapy is reported. The hematoma resolved spontaneously within two weeks without any residual complications such as esophageal stricture. Can J Gastroenterol 1990;4( 1 )123·25

Key Words: Hematoma, Portal hypertension, Sclerotherapy

Hematome oesophagien sous•muqueux consecutif a une sclero· therapie: Une complication rare

RESUME: Un patient cirrhotique a developpe un hematome intramural de l'oesophage, complication d 'une sclerotherapie administree clans le traitement des varices oesophagiennes. L'hematome s'est resolu spontanement en l'espace de deux semaines sans aucune complication residuelle - stenose esophagienne, par exem pie.

ENDOSCOPIC SCLEROTHERAl'Y IS NOW

considered an important therapeutic modality in the management of variceal hemorrhages. There is now enough data to show that endoscopic sclerotherapy significantly reduces rebleeding risk ( 1-3 );

however, its effect on the survival of pa­tients with cirrhosis is still controversial (2-4). Various complications of endo­scopic sclerothe rapy have been described in the literature (5,6). This report deals with an extremely unusual complication .

Departments of He/>awlogy, Experimencal Medicine and Rad1odiagnosis, Posrgraduate ln.mrute o{Medical Education and Research, Chandigarh-160012, India

Correspondence and reprint1. Dr JB Dilawari, Associate Professor and Head, Departmenr of Hepawlogy, Postgraduate lnstirute of Medical Education and Research, Cha11d1garh-160012. India

Received/or publicarion]unc 7. 1989. Accepted September 9, !989

CAN J GASTROENTEROL VOL 4 No l JANUARY/FEBRUARY 1990

CASE PRESENTATION A 55-ycar-olJ female presented in

September 1986 wirh massive hemate­mesi~ and mclena, which were diagnosed to be variceal in origin on endoscopy. She had normal liver function tests; how­ever, a biopsy of the liver showed ci r­rhosis. After initia l control of the bleed using a Sengstaken-Blakemore tube, the patient was started on endoscopic sclero­therapy (EST). EST was performed with I% sodium tetradecyl sulphate at three­week in tervals using an O lympus fibre­scope. The varices decreased in size from grade lll co grade II after six sessions.

During the seventh session of sclero­thcrapy, one grade II va ri x was injected with I mLof the sclerosant. The patient did not complain of pain during or imm­ediately after the procedure . Over the next 12 h, however, she developed a pro· gressive dysphagia to both solids and liq­uids including saliva, along with severe retrosternal pain.

On examination there was no hepato· splenomegaly and the lungs were clear. The patient had a no rmal coagulogra m which was done soon after the compli­cation occurred.

23

Page 2: Submucosal esophageal hematon1a fallowing sclerotherapy: A …downloads.hindawi.com/journals/cjgh/1990/715941.pdf · BRIEF COMMUNICATION Submucosal esophageal hematon1a fallowing

SINGH era/

Figure 1) Left Barium swallow done che day after che complication, showing a filling defeci which gives che esophagus che appearance of ha11ing a double lumen. Right Barium swallow showing a normal looking csophaKus after cwo weeks of conservative therapy

An esophagogram with gastro conray (Conray 280; May & Baker.India) (Figure l) showed an apparent double lumen of the esophagus. There was no extramural

leakage of the dye. Chest radiodiogram was normal. Upper gastrointestinal endo­scopy revealed narrowing of the esopha­geal lumen 24 cm from the incisors with

a dusky bluish nodular elevation com· pletely occluding the lumen of the esoph· agus, suggestive of a submucosal hema· toma. A computed tomography scan of the thorax revealed that the hematoma was confined co the submucosa of the esophagus, producing a double lumen effect (Figure 2).

The patient was kept nil by mouth and started on intravenous fluids. After 48 h she showed some improvement, being able to swallow liquids. After two weeks she could swallow solids without discom· fort. The patien t remained a febrile over the two week symptomatic period. A re· peat esophagogram after two weeks re· vealed a normal esophagus (Figure I) while endoscopy showed an area of hy­peremia at the site of hemacoma extend­ing from 24 to 32 cm, without any nar­rowing of the lumen of the esophagus. A repeat computed tomography scan of the thorax confirmed the disappearance of the hematoma (Figure 2).

DISCUSSION This case demonstrates a most unusual

complication of sclerotherapy. The sud­den and rapid ly progressive dysphagia which developed within hours of EST, and the finding of a large dusky bluish submucosal lesion obstructing the lumen of the esophagus made hematoma a likely diagnosis, which was supported by a computed tomography scan .

Awareness of the occurrence of this hematoma as a complication of sclero·

Figure 2) Left Computed wmography scan showing an intramural hemawma in 1hesubmucosa of the esophagus, producing a double lumen effect. Right Compu1ed wmography scan showing 1he absence of hemaroma after conseniarive trea1men1. A Bronchus; 8 Esophagus; C Hemaroma

24 CAN ) GASTROENTEROL VOL 4 No I JANUARY/FEBRUARY 1990

Page 3: Submucosal esophageal hematon1a fallowing sclerotherapy: A …downloads.hindawi.com/journals/cjgh/1990/715941.pdf · BRIEF COMMUNICATION Submucosal esophageal hematon1a fallowing

therapy will aid in the recognitio n of this condition aftersclcrothcrapy, p resenting with a sudden onset of severe rerrosternal pain and dysphagia. S imilar sympto ms have been previously reported (6,7) .

When an intravariceal injection is at­tempted using a free hand technique, some extravasation of the sclerosant into the surrounding tissues is inevitable (8).

REFERENCES l. Clark AW, Westaby D, Silla OBA. et al.

Prospective contro lled trial of injection sclerothcrapy in patients with cirrhosis and recent variceal haemorrhage. Lancet l980;ii:552-4 .

2. KorulaJ, Balan LA, Radvan G, etal. A prospective randomised con­trolled trial of ch ronic oesophageal variceal sderothcrapy. Hcpatology 1985;5:585-9

3. TerblancheJ , Bornman PC, Kahn D , et al. Failure of repeated injection sclerotherapy to improve long term survival after oesophageal variccal

Necrosis and hemorrhage into submu­cosal tissue from the submucosal vessels may have caused the hematoma follow­ing sclerotherapy.

Management of such lesions should be conservative, as is evident from this case study. Spontaneous resolution has been known to occur without any residual defects such as stricture or dysmotility.

bleeding. A five year p rospective controlled clinical trial. Lancet 1983:ii: 1328-32.

4. MacDougall BRO, Westaby D, Theod ossi A, et al. Increased long term su rvival in variceal hemorrhage using injection sclerotherapy. Lancet 1982:ii: 124-7.

5. Galambos T. Endoscopic sclerotherapy. Ann Intern Med 1983;93: 1009- l 1. (Edit)

6. KorulaJ . Pseudotumourofthc esophagus. An unusual complication of esophageal variceal sclerotherapy. Am J Gastroenterol I 985;80:954-6.

7. Jones DB, Frost RA, Goodacre RL

Complication of endoscopic sclerotheropy

In tramural he mato masof the esopha­gus have also been described in the liter­ature following prorracted vomiting in the absence of preceding instrumentatio n (9.10). Such hematomas usually occur in the distal esophagus fo llowing a Mallory­Weiss laceration. Patien ts with impaired coagulation may also develop a hcmatoma without having vomi ted beforehand .

lntramural hem~torna of the esophagus - A complication of endoscopic injection sclerotherapy. Gasrrointest Endosc 1986:32:2 39-40.

8. Ayres SJ. Geoff JS. Warscn G H. Endoscopic sclerotherapy fo r bleeding esophageal varices: Effects and compli­catio ns. Ann Intern Med 1983;98:900-3.

9. Kerr WF. Spo ntaneous intramural rupture and intramural hematoma of the esophagus. Thorax I 980;35:890-7

10. Srevens S, Bernndson RA, Johnson LF. Esophageal hematoma. Four new cases. A review and proposed etiology. Dig Dis Sci 198 1 ;26: JOI 9-24.

Page 4: Submucosal esophageal hematon1a fallowing sclerotherapy: A …downloads.hindawi.com/journals/cjgh/1990/715941.pdf · BRIEF COMMUNICATION Submucosal esophageal hematon1a fallowing

Submit your manuscripts athttp://www.hindawi.com

Stem CellsInternational

Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014

Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014

MEDIATORSINFLAMMATION

of

Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014

Behavioural Neurology

EndocrinologyInternational Journal of

Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014

Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014

Disease Markers

Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014

BioMed Research International

OncologyJournal of

Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014

Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014

Oxidative Medicine and Cellular Longevity

Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014

PPAR Research

The Scientific World JournalHindawi Publishing Corporation http://www.hindawi.com Volume 2014

Immunology ResearchHindawi Publishing Corporationhttp://www.hindawi.com Volume 2014

Journal of

ObesityJournal of

Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014

Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014

Computational and Mathematical Methods in Medicine

OphthalmologyJournal of

Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014

Diabetes ResearchJournal of

Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014

Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014

Research and TreatmentAIDS

Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014

Gastroenterology Research and Practice

Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014

Parkinson’s Disease

Evidence-Based Complementary and Alternative Medicine

Volume 2014Hindawi Publishing Corporationhttp://www.hindawi.com